Alteration of skeletal muscle energy metabolism assessed by 31 P MRS in clinical routine: Part 2. Clinical application
NMR in Biomedicine · 2023
DOI: 10.1002/nbm.5031 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, 2023. Verfasst von Antoine Naëgel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Lyon, France. Hauptthemen laut MEDLINE: Energy Metabolism, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LABEX PRIMES, Siemens Healthineers, European Union's Horizon 2020 research and innovation programme.
Abstract (Originalsprache)
In this second part of a two‐part paper, we intend to demonstrate the impact of the previously proposed advanced quality control pipeline. To understand its benefit and challenge the proposed methodology in a real scenario, we chose to compare the outcome when applying it to the analysis of two patient populations with significant but highly different types of fatigue: COVID‐19 and multiple sclerosis (MS). 31 P‐MRS was performed on a 3 T clinical MRI, in 19 COVID‐19 patients, 38 MS patients, and 40 matched healthy controls. Dynamic acquisitions using an MR‐compatible ergometer ran over a rest (40 s), exercise (2 min), and a recovery phase (6 min). Long and short T R acquisitions were also made at rest for T 1 correction. The advanced data quality control pipeline presented in Part 1 is applied to the selected patient cohorts to investigate its impact on clinical outcomes. We first used power and sample size analysis to estimate objectively the impact of adding the quality control score (QCS). Then, comparisons between patients and healthy control groups using the validated QCS were performed using unpaired t tests or Mann–Whitney tests ( p < 0.05). The application of the QCS resulted in increased statistical power, changed the values of several outcome measures, and reduced variability (standard deviation). A significant difference was found between the T 1PCr and T 1Pi values of MS patients and healthy controls. Furthermore, the use of a fixed correction factor led to systematically higher estimated concentrations of PCr and P i than when using individually corrected factors. We observed significant differences between the two patient populations and healthy controls for resting [PCr]—MS only, [P i ], [ADP], [H 2 PO 4 − ], and pH—COVID‐19 only, and post‐exercise [PCr], [P i ], and [H 2 PO 4 − ]—MS only. The dynamic indicators τ PCr , τ Pi , V iPCr , and V max were reduced for COVID‐19 and MS patients compared with controls. Our results show that QCS in dynamic 31 P‐MRS studies results in smaller data variability and therefore impacts study sample size and power. Although QCS resulted in discarded data and therefore reduced the acceptable data and subject numbers, this rigorous and unbiased approach allowed for proper assessment of muscle metabolites and metabolism in patient populations. The outcomes include an increased metabolite T 1 , which directly affects the T 1 correction factor applied to the amplitudes of the metabolite, and a prolonged τ PCr , indicating reduced muscle oxidative capacity for patients with MS and COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1206, Lyon, France.
- Siemens Healthcare SAS, Saint-Denis, France.
- Wolfson Brain Imaging Center, University of Cambridge, Cambridge, UK.
- LIBM-Laboratoire Interuniversitaire de Biologie de la Motricité, Villeurbanne, France.
- Department of Radiology, Michigan State University, East Lansing, Michigan, USA.
- Anaesthetics and Intensive Care Department, UJM-Saint-Étienne, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France.
ORCID-Profile: Antoine Naëgel, Hélène Ratiney, Jabrane Karkouri, Djahid Kennouche, Pierre Croisille, Magalie Viallon
Förderung
- LABEX PRIMES
- Siemens Healthineers
- European Union's Horizon 2020 research and innovation programme
Zitieren
APA
Naëgel, A., Ratiney, H., Karkouri, J., Kennouche, D., Royer, N., Slade, J. M., Morel, J., Croisille, P., & Viallon, M. (2023). Alteration of skeletal muscle energy metabolism assessed by 31 P MRS in clinical routine: Part 2. Clinical application. NMR in Biomedicine. https://doi.org/10.1002/nbm.5031
Vancouver
Naëgel A, Ratiney H, Karkouri J, Kennouche D, Royer N, Slade JM, et al. Alteration of skeletal muscle energy metabolism assessed by 31 P MRS in clinical routine: Part 2. Clinical application. NMR in Biomedicine. 2023. doi:10.1002/nbm.5031
BibTeX
@article{Nagel2023,
author = {Naëgel, Antoine and Ratiney, Hélène and Karkouri, Jabrane and Kennouche, Djahid and Royer, Nicolas and Slade, Jill M and Morel, Jérôme and Croisille, Pierre and Viallon, Magalie},
title = {Alteration of skeletal muscle energy metabolism assessed by 31 P MRS in clinical routine: Part 2. Clinical application},
journal = {NMR in Biomedicine},
year = {2023},
doi = {10.1002/nbm.5031}
}
EUVIMED